Jazz Pharmaceuticals plc — Director's Dealing 2019

Nov 8, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2019-10-31

Reporting Person: Larkin Finbar (SVP, Technical Development)

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	8488	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-Qualified Stock Option (right to buy)	$58.72	2023-05-02	Ordinary Shares (1706)		Direct
Non-Qualified Stock Option (right to buy)	$123.36	2026-02-24	Ordinary Shares (5658)		Direct
Non-Qualified Stock Option (right to buy)	$136.18	2027-03-01	Ordinary Shares (5560)		Direct
Non-Qualified Stock Option (right to buy)	$140.03	2029-02-27	Ordinary Shares (5355)		Direct
Non-Qualified Stock Option (right to buy)	$140.67	2028-02-29	Ordinary Shares (5000)		Direct
Non-Qualified Stock Option (right to buy)	$166.62	2024-02-26	Ordinary Shares (4300)		Direct
Non-Qualified Stock Option (right to buy)	$168.8	2028-09-05	Ordinary Shares (1200)		Direct
Non-Qualified Stock Option (right to buy)	$175.19	2025-02-25	Ordinary Shares (3469)		Direct

Footnotes

F1: Consists of (1) 187 shares of 1,575 RSUs granted on May 3, 2013 (1,388 having been sold), (2) 473 shares of 1,334 RSUs granted on February 26, 2015 (861 having been sold), (3) 565 unvested RSUs plus 807 shares of the original 2,263 RSUs granted on February 25, 2016 (891 having been sold), (4) 1,112 unvested RSUs plus 530 shares of the original 2,224 RSUs granted on March 2, 2017 (582 having been sold), (5) 1,500 unvested RSUs plus 238 shares of the original 2,000 RSUs granted on March 1, 2018 (262 having been sold), (6) 360 unvested RSUs plus 57 shares of the original 480 RSUs granted on September 6, 2018 (63 having been sold) and (7) 2,142 unvested RSUs granted on February 28, 2019, all of which were granted pursuant to the Issuer's 2011 Equity Issuer Plan. Each RSU grant vests in four equal annual installments, and the remaining unvested RSUs will vest on various dates between February 25, 2020 and March 5, 2023.

F2: Includes 517 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on purchase dates between May 30, 2014 and May 31, 2019.

F3: These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vested over four years measured from the grant date, May 3, 2013, with 1/4th vesting on April 9, 2014 and the remainder vesting in 36 equal monthly installments thereafter. The option is fully vested and exercisable as of the date of this Form.

F4: These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 25, 2016, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.

F5: These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, March 2, 2017, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.

F6: These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 28, 2019, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.

F7: These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, March 1, 2018, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.

F8: These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vested over four years measured from the grant date, February 27, 2014, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter. The option is fully vested and exercisable as of the date of this Form.

F9: These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, September 6, 2018, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.

F10: These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vested over four years measured from the grant date, February 26, 2015, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter. The option is fully vested and exercisable as of the date of this Form.